MedPath

The role of non-contrast abbreviated MRI for secondary surveillance of hepatocellular carcinoma after curative treatment: prospective multicenter study

Not Applicable
Conditions
Neoplasms
Registration Number
KCT0006395
Lead Sponsor
Seoul National University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
210
Inclusion Criteria

1) Patients giving written informed consent to participate in this study.
2) age between 20-year-old and 85-year-old
3) patients who underwent curative treatment using either surgical resection or local ablation for hepatocellular carcinoma (HCC) with more than a-2-year period of NED (no evidence of disease)
4) patients who have a schedule of contrast-enhanced CT to detect secondary HCC
5) No claustrophobia

Exclusion Criteria

1) age below 20 or age over 85
2) patients with claustrophobia
3) patients with a cardiac pacemaker or cochlear implants

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity for detection of secondary HCC
Secondary Outcome Measures
NameTimeMethod
Specificity for detection of secondary HCC;Positive predictive value for detection of secondary HCC;Negative predictive value for detection of secondary HCC
© Copyright 2025. All Rights Reserved by MedPath